Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

Clinical trial NCT05608148 · RECRUITING

Trial details

NCT number: NCT05608148
Sponsor: Kyushu University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory/Relapse Neuroblastoma Pediatric Solid Tumors

Start date: 2022-10-26
Primary completion: 2027-08-25
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.